肽类与激素疗法：健康、表现与长寿
摘要
Dr. Craig Koniver 是一位专注于”表现医学”的执业医师，他详细介绍了肽类和激素在改善心理健康、身体健康及整体表现方面的临床应用。对话涵盖了从广为人知的 GLP-1 激动剂，到鲜为人知的生长激素促泌剂和组织修复肽等一系列化合物。核心主题在于将这些工具作为辅助手段——而非替代手段——来增强人体自然激素系统，同时强调医师监督和原料来源的纯净性。
关键要点
- 肽类介于生活方式干预与直接激素疗法之间：它们能够激活内源性激素通路，同时不触发抑制自然分泌的负反馈回路。
- 微剂量 GLP-1 激动剂（司美格鲁肽/替泽帕肽）以复方低剂量使用——目标为每周体重减少不超过 2 磅——可在很大程度上预防标准临床剂量带来的肌肉流失和”OIC 面容”问题。
- BPC-157 已被广泛用于全身抗inflammation和组织修复；皮下注射的效果优于口服，即便对于肠道相关问题亦然。该物质现已被 FDA 从复方药房许可名单中移除，但**五肽精氨酸（PDA）**正作为密切相关的替代品崭露头角。
- 生长激素促泌剂（如 ipamorelin，最大剂量 100 mcg）在睡前注射效果最佳，注射前约 45 分钟内避免进食，以配合人体夜间自然的 GH 脉冲分泌节律。
- 肽类叠加使用（例如 ipamorelin + tesamorelin + BPC-157）以较低的单独剂量组合，可在脂肪减少、瘦体重增加、睡眠质量和恢复能力方面产生协同效应。
- **辅酶 Q10（每日 200 mg）**和甲基化 B 族维生素是 Dr. Koniver 基于其在线粒体电子传递链中的作用而持续推荐的少数几种补充剂之一。
- 来源质量至关重要：复方药房受 FDA 及药学委员会监管，须经第三方纯度检测，生产无菌化合物——这与灰色/黑市”研究用”肽类截然不同，后者常含有引发炎症的内毒素（LPS）。
- 年轻男性接受睾酮替代治疗存在真实的生育风险；在医师指导下使用最低有效剂量，并选择生理变量性给药方式（注射剂与缓释颗粒相比），是更为推荐的做法。
详细笔记
什么是肽类？
- 肽类是由 40 个氨基酸或更少氨基酸组成的链状结构；蛋白质则由 41 个或更多氨基酸组成。
- 人体估计可产生约 300,000 种肽；迄今为止仅约 150 种已用于治疗。
- 由于肽类模拟或激活天然存在的信号分子，它们通常不会触发抑制内源性激素产生的负反馈回路——这是相较于直接激素给药的关键优势。
GLP-1 激动剂（司美格鲁肽 / 替泽帕肽）
- 最初经 FDA 批准用于2 型糖尿病的血糖管理；体重减轻作为次要效应被观察到。
- 现广泛用于超适应症减重——这是常见做法：美国处方药中的大多数均为超适应症使用。
- Dr. Koniver 的临床转变：早期使用常导致体重下降过快（3 周内减重 15 磅），引发肌肉流失和面部脂肪流失（“OIC 面容”）。
- 首选方案：复方微剂量替泽帕肽/司美格鲁肽，缓慢滴定。
- 目标：每周体重减少 ≤2 磅，以保留瘦体重。
- 配合：充足蛋白质摄入 + 抗阻训练。
- 除减重外，患者还报告了：认知改善、炎症减轻以及自身免疫指标下降（例如桥本甲状腺炎患者的甲状腺过氧化物酶抗体下降）。
- 对于依赖性的顾虑已被认可，但需与切实的生活质量改善进行权衡；秉持”先赢得这场比赛，再为下一场比赛备战”的理念。
BPC-157（身体保护化合物 157）
- 一种来源于肠道的肽，可耐受口服摄入，但皮下注射时显示出更强的全身效应。
- 临床观察到的主要用途：全身抗炎、肌腱/韧带修复、病毒感染后恢复、胃肠道疾病（克罗恩病、炎症性肠病、肠漏综合征）。
- 关键机制要点：
- 刺激成纤维细胞迁移，促进结缔组织修复。
- 上调生长激素受体，使 GH 促泌剂叠加使用时更为有效。
- 发挥全身性作用——在腹部附近注射可使远端损伤部位（如肘部、跟腱）获益。
- 临床使用方案：500–5,000 mcg/天，用 5 天 / 停 2 天。
- 也可静脉注射作为”启动”，以激活抗炎级联反应，随后通过皮下给药维持持续效果。
- FDA 状态：2023 年 10 月被列入第 2 类”禁止复方配制”名单；近期已从合法复方渠道中撤除。
替代品：五肽精氨酸（PDA）
- 与 BPC-157 具有相同的核心分子结构；一个氨基酸替换（乙酸盐 → 精氨酸盐）。
- 早期临床观察显示具有相当的抗炎效果。
- 起始方案：500 mcg 皮下注射，用 5 天 / 停 2 天。
- 目前未观察到明显副作用。
生长激素促泌剂（GHS）
这类肽刺激垂体释放内源性生长激素（GH），后者随后到达肝脏产生 IGF-1，促进生长、愈合和恢复。
| 肽类 | 机制 / 特点 | 备注 |
|---|---|---|
| Ipamorelin | 受体选择性最高；作用谱最清晰 | 最大 100 mcg；塑形减脂、改善睡眠、不引起食欲增加 |
| GHRP-6 | 结合 GH 受体 + 催乳素 + ACTH | 增加食欲/皮质醇；最适合增肌 |
| Tesamorelin | GHRH 类似物 | 靶向内脏脂肪；已获 FDA 批准用于 HIV 脂肪代谢障碍；在女性中可能效果更佳 |
| Sermorelin | GHRH 类似物 | 与 tesamorelin 类似；在某些个体中可能影响 PSA 和 REM 睡眠 |
| CJC-1295 | 延长 GH/GHRH 在血液中的作用时间 | 短暂禁用后近期重新获得 FDA 批准 |
| Epitalon | — | 近期重新获得 FDA 批准 |
| 胸腺素 Beta Alpha | 抗炎 / 组织修复 | 近期重新获得 FDA 批准 |
GHS 通用方案：
- 睡前皮下注射
- 注射前约 45 分钟内不摄入碳水化合物（胰岛素会抑制 GH 释放）
- 用 5 天 / 停 2 天（与传统 GH 用药周期一致）
- 周末停药的原因：防止受体脱敏，维持药效
睡眠时机说明：人体最大的自然 GH 脉冲大约发生在晚上 10 点至凌晨 2 点；GHS 的夜间给药与这一脉冲同步并加以放大。
肽类叠加示例
脂肪减少 / 身体重塑叠加方案（禁用前）：
- BPC-157 → 上调 GH 受体
- Ipamorelin → 皮下脂肪减少
- Tesamorelin → 内脏脂肪减少
综合报告效果：瘦体重增加、睡眠改善、皮肤状态变好、恢复加快、认知提升——均通过复方制剂每晚一次皮下注射实现。
禁用后替代方案：在叠加组合中以五肽精氨酸（PDA）替换 BPC-157。
睾酮及相关激素
- 睾酮适用于有明确性腺功能减退症记录的男性及女性的testosterone replacement therapy；使用应在医师监督下进行。
- 生育风险：外源性睾酮会抑制精子生成；无监督使用的年轻男性面临精子计数归零的风险。恢复需要使用氯米芬、HCG 或特定肽类等药物。
- **南德龙（Deca
English Original 英文原文
Peptide & Hormone Therapies for Health, Performance & Longevity
Summary
Dr. Craig Koniver, a board-certified physician specializing in “performance medicine,” walks through the clinical applications of peptides and hormones for improving mental health, physical health, and performance. The conversation covers a spectrum from widely known compounds like GLP-1 agonists to lesser-known growth hormone secretagogues and tissue-repair peptides. A central theme is using these tools to augment—rather than replace—the body’s natural hormone systems, while emphasizing physician oversight and clean sourcing.
Key Takeaways
- Peptides sit between lifestyle interventions and direct hormone therapies: They can stimulate endogenous hormone pathways without triggering the negative feedback loops that shut down natural production.
- Microdosing GLP-1 agonists (semaglutide/tirzepatide) at compounded, low doses—targeting no more than 2 lbs of weight loss per week—can largely prevent the muscle loss and “OIC face” associated with standard clinical dosing.
- BPC-157 has been widely used for systemic anti-inflammation and tissue repair; subcutaneous injection outperforms oral dosing even for gut-related issues. It has now been removed from compounding pharmacy lists by the FDA, but Pentadeca Arginate (PDA) is emerging as a closely related substitute.
- Growth hormone secretagogues like ipamorelin (100 mcg max) work best injected at bedtime, without food for ~45 minutes prior, to align with the body’s natural overnight GH pulse.
- Stacking peptides (e.g., ipamorelin + tesamorelin + BPC-157) at lower individual doses can produce synergistic effects on fat loss, lean muscle, sleep quality, and recovery.
- CoQ10 (200 mg/day) and methylated B vitamins are among the few supplements Dr. Koniver consistently recommends, based on their role in mitochondrial electron transport.
- Source quality is critical: Compounding pharmacies are FDA and Board of Pharmacy regulated, require outside purity testing, and produce sterile compounds—unlike gray/black market “research” peptides that often contain inflammatory endotoxins (LPS).
- Testosterone replacement in young men carries real fertility risks; working with a physician to use the lowest effective dose, in physiologically variable delivery forms (injectable vs. pellets), is strongly preferred.
Detailed Notes
What Are Peptides?
- Peptides are chains of 40 amino acids or fewer; proteins are 41+ amino acids.
- The human body produces an estimated 300,000 peptides; only ~150 have been used therapeutically to date.
- Because they mimic or stimulate naturally occurring signaling molecules, they generally do not trigger the negative feedback loops that suppress endogenous hormone production—a key advantage over direct hormone administration.
GLP-1 Agonists (Semaglutide / Tirzepatide)
- Originally FDA-approved for type 2 diabetes glucose management; weight loss was observed as a secondary effect.
- Now prescribed widely off-label for weight loss—a common practice: the majority of drugs prescribed in the U.S. are used off-label.
- Dr. Koniver’s clinical shift: early use often resulted in too-rapid weight loss (15 lbs in 3 weeks), leading to muscle loss and facial fat loss (“OIC face”).
- Preferred approach: Compounded microdose tirzepatide/semaglutide, titrated slowly.
- Target: ≤2 lbs weight loss per week to preserve lean muscle mass.
- Pair with: adequate protein intake + resistance training.
- Beyond weight loss, patients report: cognitive improvements, reduced inflammation, and lower autoimmune markers (e.g., thyroid peroxidase antibodies in Hashimoto’s patients).
- Dependency concern is acknowledged but weighed against real quality-of-life improvements; the “win the race first, then train for the next race” philosophy.
BPC-157 (Body Protection Compound 157)
- A gut-derived peptide that survives oral ingestion but shows stronger systemic effects when injected subcutaneously.
- Primary uses observed clinically: systemic anti-inflammation, tendon/ligament repair, post-viral recovery, GI conditions (Crohn’s, IBD, leaky gut).
- Key mechanism notes:
- Stimulates fibroblast migration for connective tissue repair.
- Upregulates growth hormone receptors, making GH secretagogues more effective when stacked together.
- Works systemically—injecting near the abdomen benefits distant injury sites (e.g., elbow, Achilles).
- Protocol used clinically: 500–5,000 mcg/day, 5 days on / 2 days off.
- Also used IV as a “spark” to initiate anti-inflammatory cascades, followed by subcutaneous dosing for sustained effect.
- FDA Status: Placed on the Category 2 “no compounding” list in October 2023; recently removed from legitimate compounding channels.
Substitute: Pentadeca Arginate (PDA)
- Same core molecular structure as BPC-157; one amino acid substitution (acetate → arginate).
- Early clinical observations suggest comparable anti-inflammatory effects.
- Starting protocol: 500 mcg subcutaneous injection, 5 days on / 2 days off.
- No notable side effects observed so far.
Growth Hormone Secretagogues (GHS)
These peptides stimulate the pituitary gland to release endogenous growth hormone (GH), which then travels to the liver to produce IGF-1, promoting growth, healing, and recovery.
| Peptide | Mechanism / Flavor | Notes |
|---|---|---|
| Ipamorelin | Most receptor-specific; cleanest profile | 100 mcg max; lean-out, better sleep, no appetite spike |
| GHRP-6 | Binds GH receptor + prolactin + ACTH | Increases appetite/cortisol; best for mass gain |
| Tesamorelin | GHRH analog | Targets visceral fat; FDA-approved for HIV lipodystrophy; may work better in females |
| Sermorelin | GHRH analog | Similar to tesamorelin; may affect PSA and REM sleep in some individuals |
| CJC-1295 | Extends GH/GHRH action in bloodstream | Recently re-approved by FDA after brief ban |
| Epitalon | — | Recently re-approved by FDA |
| Thymosin Beta Alpha | Anti-inflammatory / tissue repair | Recently re-approved by FDA |
General GHS Protocol:
- Inject subcutaneously at bedtime
- No carbohydrates within ~45 minutes of injection (insulin blunts GH release)
- 5 days on / 2 days off (mirrors traditional GH dosing cycles)
- Rationale for weekend break: prevents receptor desensitization and maintains potency
Sleep timing note: The largest natural GH pulse occurs roughly 10 PM–2 AM; nighttime dosing of GHS aligns with and amplifies this pulse.
Peptide Stacking Example
Fat loss / body recomposition stack (pre-ban):
- BPC-157 → upregulates GH receptors
- Ipamorelin → subcutaneous fat reduction
- Tesamorelin → visceral fat reduction
Combined effects reported: lean muscle gain, improved sleep, better skin, faster recovery, cognitive improvements—all in one subcutaneous injection per night via compounded formulation.
Post-ban substitution: Replace BPC-157 with Pentadeca Arginate in the stack.
Testosterone & Related Hormones
- Testosterone is appropriate for testosterone replacement therapy in men with documented hypogonadism and in women; use should be supervised by a physician.
- Fertility risk: Exogenous testosterone suppresses spermatogenesis; young men using it unsupervised face risk of zero sperm count. Recovery requires agents like clomiphene, HCG, or specific peptides.
- **Nandrolone (Deca